THOMAS HADDOCK: Open Payments
NPI 1255067872 · AYDEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 37 payments from 12 companies in 2025. Trend: 2023 $1,119 · 2024 $952 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $149 |
| PFIZER INC. | 3 | $66 |
| ABBVIE INC. | 3 | $55 |
| Novo Nordisk Inc | 3 | $55 |
| Lilly USA, LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: OTEZLA, MOUNJARO, ELIQUIS, TZIELD, VRAYLAR, LEQVIO, AIRSUPRA, XIFAXAN.
Industry payments across NC — which companies pay providers there.
